EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lincosamide monotherapy treatment of methicillin-resistant Staphylococcus aureus pneumonia in tropical Australia: a case series

Stuart Campbell, Simon Smith, Josh Hanson

European Journal of Clinical Microbiology & Infectious Diseases · 2024

DOI: 10.1007/s10096-024-04816-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Stuart Campbell und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Cairns Hospital, Cairns, Queensland, Australia. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus aureus, Pneumonia, Staphylococcal, Lincosamides. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of New South Wales.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Existing recommended first-line antibiotic agents for MRSA pneumonia have several shortcomings. We reviewed 29 cases of community- and hospital-acquired MRSA pneumonia managed at our hospital. Lincosamide monotherapy was administered to 21/29 (72%) and was the predominant antibiotic regimen (> 50% course duration) in 19/29 (66%). Patients receiving lincosamide-predominant monotherapy were no more likely to die or require intensive care unit admission than patients receiving vancomycin-predominant monotherapy (5/19 (26%) versus 4/7 (57%), p = 0.19); 5/7 (71%) patients admitted to ICU and 4/5 (80%) bacteraemic patients received lincosamide-predominant monotherapy. MRSA pneumonia can be safely treated with lincosamide monotherapy if the isolate is susceptible.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsMethicillin-Resistant Staphylococcus aureusPneumonia, StaphylococcalLincosamidesHumansMaleFemaleMiddle AgedAdultAgedAustraliaTreatment OutcomeRetrospective StudiesYoung AdultCommunity-Acquired InfectionsCross InfectionAged, 80 and over

Stichwörter der Autor:innen

Antibiotic therapy.Critical illnessLincosamidesMethicillin-resistantPneumoniaStaphylococcus aureus

Substanzen

Anti-Bacterial AgentsLincosamides

Autor:innen und Institutionen

  • Department of Medicine, Cairns Hospital, Cairns, Queensland, Australia.
  • Department of Medicine, Cairns Hospital, Cairns, Queensland, Australia. jhanson@kirby.unsw.edu.au.
  • The Kirby Institute, University of New South Wales, Sydney, Australia. jhanson@kirby.unsw.edu.au.

Förderung

  • University of New South Wales

Zitieren

APA

Campbell, S., Smith, S., & Hanson, J. (2024). Lincosamide monotherapy treatment of methicillin-resistant Staphylococcus aureus pneumonia in tropical Australia: a case series. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04816-9

Vancouver

Campbell S, Smith S, Hanson J. Lincosamide monotherapy treatment of methicillin-resistant Staphylococcus aureus pneumonia in tropical Australia: a case series. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04816-9

BibTeX
@article{Campbell2024,
  author = {Campbell, Stuart and Smith, Simon and Hanson, Josh},
  title = {Lincosamide monotherapy treatment of methicillin-resistant Staphylococcus aureus pneumonia in tropical Australia: a case series},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2024},
  doi = {10.1007/s10096-024-04816-9}
}
Kostenlos starten →